2022 AMI Online Salon

Sana: Hypoimmune MOA animation

Project Detail

  • Entrant Name:  David Ehlert
  • Client: Sana Biotechnology
  • Copyright: Sana Biotechnology, 2022
  • Medium/software used: C4D, After Effects, Illustrator
  • Final presentation format: Website/conference video
  • Primary Audience: Investors, potential partners, future recruits

Project Description

Sana Biotechnology brings together research, development, and manufacturing capabilities across cell therapy, gene therapy, and gene editing to be at the threshold of a new era of medicines. Sana is developing novel platforms to address unmet medical needs across a spectrum of diseases by overcoming immune rejection from transplanting “non-self” cells.For one of these platforms, Sana was looking to create a high-level, one-minute overview animation for their website that could connect with a broad audience (from the general public to science-based investors) and introduce them to the possibilities of the platform and the primary process involved in creating it. This ex vivo Hypoimmune Technology Platform can modulate damaged cells precisely with reproducible outcomes while overcoming immune rejection, a major hurdle in addressing unmet medical needs across a spectrum of diseases, potentially impacting numerous patients’ lives.We intended to create a visually bright and engaging animation that would feel cohesive with Sana’s brand while elevating its visual approach into 3D space. Cohesive design elements (such as abstracted lines, lights, and clean iconography) were used to explain the development of hypoimmune cells in a high-level manner. Care was also taken to how the patient population was depicted to suggest that the platform could be applied across all demographics.